BioElectronics Corporation (BIEL)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
-0.0001 (-33.33%)
Mar 9, 2026, 3:07 PM EST
BioElectronics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2016 - 2012 |
|---|---|---|---|---|---|---|
Period Ending | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2016 - 2012 |
| Revenue | 1.61 | 0.83 | 0.94 | 1.05 | 1.76 | Upgrade
|
| Revenue Growth (YoY) | 94.01% | -11.91% | -9.96% | -40.70% | -15.60% | Upgrade
|
| Cost of Revenue | 0.81 | 0.32 | 0.41 | 0.69 | 0.77 | Upgrade
|
| Gross Profit | 0.8 | 0.51 | 0.53 | 0.36 | 1 | Upgrade
|
| Selling, General & Admin | 0.6 | 1.04 | 1.12 | 1.8 | 1.88 | Upgrade
|
| Research & Development | 0.33 | 0.48 | 0.66 | 0.5 | 0.39 | Upgrade
|
| Operating Expenses | 0.93 | 1.54 | 1.84 | 2.37 | 2.29 | Upgrade
|
| Operating Income | -0.14 | -1.03 | -1.31 | -2.01 | -1.3 | Upgrade
|
| Interest Expense | -0.31 | -0.26 | -0.99 | -0.95 | -0.76 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.08 | 0.14 | -0.03 | -0.03 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | -0.53 | -1.16 | -2.33 | -2.99 | -2.12 | Upgrade
|
| Other Unusual Items | 0.24 | - | - | - | - | Upgrade
|
| Pretax Income | -0.29 | -1.16 | -2.33 | -2.99 | -2.12 | Upgrade
|
| Net Income | -0.29 | -1.16 | -2.33 | -2.99 | -2.12 | Upgrade
|
| Net Income to Common | -0.29 | -1.16 | -2.33 | -2.99 | -2.12 | Upgrade
|
| Shares Outstanding (Basic) | 24,257 | 23,526 | 21,812 | 19,849 | 16,979 | Upgrade
|
| Shares Outstanding (Diluted) | 24,257 | 23,526 | 21,812 | 19,849 | 16,979 | Upgrade
|
| Shares Change (YoY) | 3.11% | 7.86% | 9.89% | 16.91% | 32.23% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | -0.32 | -0.53 | -0.72 | -1.35 | -0.87 | Upgrade
|
| Gross Margin | 49.43% | 61.02% | 56.24% | 34.17% | 56.59% | Upgrade
|
| Operating Margin | -8.52% | -124.50% | -138.68% | -192.19% | -73.52% | Upgrade
|
| Profit Margin | -18.01% | -139.80% | -246.91% | -285.73% | -120.13% | Upgrade
|
| Free Cash Flow Margin | -19.90% | -63.65% | -75.99% | -129.31% | -49.26% | Upgrade
|
| EBITDA | - | -1.03 | -1.31 | -2.01 | -1.29 | Upgrade
|
| EBITDA Margin | - | -124.40% | -138.59% | -191.97% | -73.39% | Upgrade
|
| D&A For EBITDA | - | 0 | 0 | 0 | 0 | Upgrade
|
| EBIT | -0.14 | -1.03 | -1.31 | -2.01 | -1.3 | Upgrade
|
| EBIT Margin | -8.52% | -124.50% | -138.68% | -192.19% | -73.52% | Upgrade
|
| Advertising Expenses | - | - | 0 | 0.14 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.